FPR2 and colitis: In the colitis model, FPR2−/− mice did not exhibit obvious body weight reduction, but showed a higher DAI compared to the wild type (WT) mice after DSS treatment (Fig 6C and D), indicating that FPR2 partially regulated the DSS‐induced colitis development, which is consistent with a previous report (Balzola et al, 2013).